Utilidad clínica de la prueba
El factor von Willebrand (FVW) es una glicoproteína compuesta por multímeros
con pesos moleculares que pueden variar desde 500 KDa hasta 20.000 kDa, que
se sintetiza en las células endoteliales y en los megacariocitos, y se almacena en
los cuerpos de Weibel-Palade y en l...
El antígeno específico de próstata (PSA, del inglés, Prostate Specific Antigen) es una glicoproteína producida por la próstata, y es el marcador tumoral de mayor uso. Sin embargo, su baja especificidad para diferenciar entre cáncer de próstata y otras alteraciones no malignas, como la hipertrofia...
Platelet activating factor is a lipid mediator of inflammation, and in recent decades, it has emerged as an important factor in tumor outcomes. Platelet activating factor acts by specific binding to its receptor, which is present in both tumor cells and cells that infiltrate tumors. Pro-tumorigenic effec...
CONTEXT AND OBJECTIVES: Glycoprotein inhibitors (abciximab, eptifibatide and tirofiban) are used in patients with unstable angina and non-ST-segment elevation myocardial infarction before percutaneous coronary intervention. Of these, tirofiban is the least effective. We hypothesized that the response to...
Myocardial infarction is usually the consequence of intravascular thrombus formation superimposed upon ruptured plaque in a coronary artery. Platelets plays a pivotal role in the initiation and thrombus formation. A lot of conflicting studies have evaluated the relations between various platelet glycopro...
